What is Artax Biopharma worth?
$58.0Mlast known valuation
Artax Biopharma last raised $19.0M in its Early Stage VC (Jul 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 8 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Artax Biopharma
Create free account
No card required
Funding history
8 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2024 | Early Stage VC | $19.0M | ▮ | ▮ |
| Dec 2021 | Early Stage VC | $25.8M | ▮ | ▮ |
| Feb 2021 | Seed Round | $2.2M | ▮ | ▮ |
| Apr 2020 | Seed Round | $2.0M | ▮ | ▮ |
| Jul 2019 | Seed Round | $750K | ▮ | ▮ |
| Jul 2015 | Seed Round | $3.0M | ▮ | ▮ |
| + 2 earlier rounds · a free account shows the full history | ||||
How Artax Biopharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Artax Biopharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Artax Biopharma worth?
- Artax Biopharma's last known valuation is $58.0M.
- How much has Artax Biopharma raised?
- Artax Biopharma has raised $51.5M in total funding across 8 recorded rounds.
- When did Artax Biopharma last raise?
- Artax Biopharma last raised in Jul 2024 (Early Stage VC), raising $19.0M.